These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 10370661)
1. Helicobacter pylori and gastroesophageal reflux disease: friends or foes? Gisbert JP; Pajares JM; Losa C Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661 [TBL] [Abstract][Full Text] [Related]
2. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?]. Zerbib F Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):427-31. PubMed ID: 12700499 [TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes? Kuipers EJ Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292 [TBL] [Abstract][Full Text] [Related]
5. GERD and H. pylori: is there a link? Falk GW Semin Gastrointest Dis; 2001 Jan; 12(1):16-25. PubMed ID: 11215851 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan. Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614 [TBL] [Abstract][Full Text] [Related]
7. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937 [TBL] [Abstract][Full Text] [Related]
8. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449 [TBL] [Abstract][Full Text] [Related]
9. [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease]. Gisbert JP; Piqué JM Med Clin (Barc); 2005 May; 124(18):697-709. PubMed ID: 15899166 [TBL] [Abstract][Full Text] [Related]
10. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease. McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566 [TBL] [Abstract][Full Text] [Related]
11. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors? Rauws EA Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835 [TBL] [Abstract][Full Text] [Related]
12. Aging and upper gastrointestinal disorders. Pilotto A Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():73-81. PubMed ID: 15588798 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Xia HH; Talley NJ Am J Gastroenterol; 1998 Mar; 93(3):394-400. PubMed ID: 9517647 [TBL] [Abstract][Full Text] [Related]
15. Ulcers and gastritis. Tytgat GN Endoscopy; 2000 Feb; 32(2):108-17. PubMed ID: 10696838 [TBL] [Abstract][Full Text] [Related]
16. The possible role of Helicobacter pylori in GERD. Falk GW Semin Gastrointest Dis; 2001 Jul; 12(3):186-95. PubMed ID: 11478751 [TBL] [Abstract][Full Text] [Related]
17. [Long-term course of reflux symptoms following Helicobacter pylori eradication]. Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962 [TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations]. Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043 [TBL] [Abstract][Full Text] [Related]
19. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy. Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043 [TBL] [Abstract][Full Text] [Related]